USPTO serial 85021985
GLYBERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 20, 2012
- Examiner
- ERVIN, INGA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GLYBERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
AMSTERDAM, NL
Amsterdam Molecular Therapeutics (AMT) IP B.V.
Amsterdam 61, NL
Other trademarks owned by Amsterdam Molecular Therapeutics (AMT) IP B.V.
Amsterdam Molecular Therapeutics (AMT) IP B.V.
Amsterdam 61, NL
Other trademarks owned by Amsterdam Molecular Therapeutics (AMT) IP B.V.
Amsterdam Molecular Therapeutics (AMT) IP B.V.
Amsterdam 61, NL
Other trademarks owned by Amsterdam Molecular Therapeutics (AMT) IP B.V.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark S. Leonardo
MARK S. LEONARDO BROWN RUDNICK LLP1 FINANCIAL CTRBOSTON, MA 02111-2621UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy vectors; biological preparations for medical use; biological preparations for medical use, namely, metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, namely, vaccines and prophylaxis products for use in nuclei acid-based therapy, gene therapy and cell therapy; gene and nucleic acid modulation for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy and prophylaxis products, namely, gene delivery and gene transfer for the treatment of metabolic disorders and disorders which are the result of one or more mutations within the lipoprotein lipase gene; all the aforementioned goods used exclusively in the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene | SECTION 8 - CANCELLED | — |
| 044 | Medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders through gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by UNIQURE IP B.V.
- Other trademarks owned by Amsterdam Molecular Therapeutics (AMT) IP B.V.
- Other trademarks owned by Amsterdam Molecular Therapeutics (AMT) IP B.V.
- Other trademarks owned by Amsterdam Molecular Therapeutics (AMT) IP B.V.
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named GLYBERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 26, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 20, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 5, 2014 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Feb 12, 2014 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 20, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 3, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 3, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 14, 2011 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 28, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 22, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 22, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 21, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 21, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 21, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 4, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 4, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 4, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 18, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 13, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 18, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 11, 2011 | ALIE | ASSIGNED TO LIE | — |
| Dec 20, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 23, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 29, 2010 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Apr 28, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 27, 2010 | NWAP | NEW APPLICATION ENTERED | — |